Figure Technology Solutions Inc.’s stock rallied 24% in its first day of trading on Thursday in a sign of sustained interest by Wall Street in the fast-growing digital-currency sector. At the closing ...

Goldman Sachs analyst Salveen Richter upgraded Ionis Pharmaceuticals (IONS) to Neutral from Sell with a price target of $65, up from $45. The firm ...

In a significant advancement for chronic hepatitis B (CHB) treatment, AusperBio Therapeutics has announced the completion of patient enrollment in two Phase II clinical trials for its lead candidate, ...

Biogen to drive end-to-end development and commercialization of ThecaFlex DRx™, an investigational implantable device for intrathecal delivery of antisense oligonucleotides (ASOs)ThecaFlex DRx™ has ...

Anthropic CEO Dario Amodei doubled down on his warning that artificial intelligence could soon cause mass unemployment, even as the technology’s current capabilities lag behind many predictions.

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers.

Antisense oligonucleotides have emerged as a promising approach for treating neurodegenerative disease. They can dial down toxic proteins or help restore functional ones, and have been approved for ...

The Persian Gulf nation has “open sourced” technology meant to compete with OpenAI and China’s DeepSeek. By Cade Metz Cade Metz has covered artificial intelligence for more than 15 years. In a move ...

Technology offers significant benefits across virtually all aspects of modern life, including improved communication, exponential growth in information access, increased productivity and automation, ...

Figure eyes a $526 million IPO, joining Circle, Bullish and Gemini in the growing wave of blockchain companies going public. Blockchain-focused lender Figure Technology Solutions is aiming to raise ...